NEXGEL, Inc. (NXGL) stock
NXGLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGLW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3069% below fair value
$3.60−0.19 (-5.13%)
Close on Nov 18, 2026Market cap $1.76MP/E –Yield –
Nexgel price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Nexgel's price to sales ratio was 3.4× on Nov 11, 2026, against 25.1× a year earlier. Over the last 5 years it ranged from 2.8× to 141.4×, with a median of 68.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.4× | −19.1 |
| 2025 | Dec 31, 2025 | 22.5× | −67.6 |
| 2024 | Dec 31, 2024 | 90.0× | +21.1 |
| 2023 | Dec 29, 2023 | 69.0× | +1.3 |
| 2022 | Dec 30, 2022 | 67.7× | −71.2 |
| 2021 | Dec 31, 2021 | 138.9× | – |
See a number that looks wrong?